TY - JOUR
T1 - One stop screening for multiple cancers
T2 - The experience of an integrated cancer prevention center
AU - Sella, Tal
AU - Boursi, Ben
AU - Gat-Charlap, Amira
AU - Aroch, Ilan
AU - Liberman, Eliezer
AU - Moshkowitz, Menachem
AU - Miller, Ehud
AU - Gur, Eyal
AU - Inbar, Roy
AU - Blachar, Arye
AU - Mabjeesh, Nicola J.
AU - Rosenfeld, Olivia
AU - Sperber, Fanny
AU - Reiser, Vadim
AU - Kleinman, Shlomi
AU - Jaffa, Ariel J.
AU - Bloch, Miki
AU - Ormianer, Mati
AU - Naumov, Inna
AU - Kazanov, Diana
AU - Kraus, Sarah
AU - Galazan, Lior
AU - Arber, Nadir
PY - 2013/4
Y1 - 2013/4
N2 - Background: Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality. Methods: We aimed to describe the experience of an integrated cancer prevention center in screening an asymptomatic population for the presence of neoplasia. One-thousand consecutive asymptomatic, apparently healthy adults, aged 20-80 years, were screened for early detection of 11 common cancers that account for 70-80% of cancer mortality. Results: Malignant and benign lesions were found in 2.4% and 7.1% of the screenees, respectively. The most common malignant lesions were in the gastrointestinal tract and breast followed by gynecological and skin. The compliance rate for the different screening procedures was considerably higher than the actual screening rate in the general Israeli population - 78% compared to 60% for mammography (p < 0.001) and 39% compared to 16% for colonoscopy (p < 0.001). Advanced age, family history of cancer and certain lifestyle parameters were associated with increased risk. Moreover, polymorphisms in the APC and CD24 genes indicated high cancer risk. When two of the polymorphisms existed in an individual, the risk for a neoplastic lesion was extremely high (OR 2.3 [95% CI 0.94-5.9]). Conclusions: One stop shop screening for 11 common cancers in the setting of a multidisciplinary outpatient clinic is feasible and can detect cancer at an early stage.
AB - Background: Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality. Methods: We aimed to describe the experience of an integrated cancer prevention center in screening an asymptomatic population for the presence of neoplasia. One-thousand consecutive asymptomatic, apparently healthy adults, aged 20-80 years, were screened for early detection of 11 common cancers that account for 70-80% of cancer mortality. Results: Malignant and benign lesions were found in 2.4% and 7.1% of the screenees, respectively. The most common malignant lesions were in the gastrointestinal tract and breast followed by gynecological and skin. The compliance rate for the different screening procedures was considerably higher than the actual screening rate in the general Israeli population - 78% compared to 60% for mammography (p < 0.001) and 39% compared to 16% for colonoscopy (p < 0.001). Advanced age, family history of cancer and certain lifestyle parameters were associated with increased risk. Moreover, polymorphisms in the APC and CD24 genes indicated high cancer risk. When two of the polymorphisms existed in an individual, the risk for a neoplastic lesion was extremely high (OR 2.3 [95% CI 0.94-5.9]). Conclusions: One stop shop screening for 11 common cancers in the setting of a multidisciplinary outpatient clinic is feasible and can detect cancer at an early stage.
KW - Cancer
KW - Early detection
KW - Genetic polymorphisms
KW - Observational
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=84875221844&partnerID=8YFLogxK
U2 - 10.1016/j.ejim.2012.12.012
DO - 10.1016/j.ejim.2012.12.012
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 23312963
AN - SCOPUS:84875221844
SN - 0953-6205
VL - 24
SP - 245
EP - 249
JO - European Journal of Internal Medicine
JF - European Journal of Internal Medicine
IS - 3
ER -